Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

Condition:   Pancreatic Cancer Interventions:   Drug: FOLFIRINOX;   Drug: Losartan;   Drug: Nivolumab;   Radiation: SBRT;   Procedure: Surgery Sponsors:   Massachusetts General Hospital;   Bristol-Myers Squibb;   Stand Up To Cancer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials